APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,559,200 | +37.2% | 72,000 | +2.9% | 0.81% | -12.6% |
| Q3 2022 | $4,781,000 | +6.6% | 70,000 | -29.4% | 0.93% | +0.8% |
| Q2 2022 | $4,484,000 | +121.9% | 99,150 | +149.3% | 0.92% | +75.3% |
| Q1 2022 | $2,021,000 | -64.4% | 39,769 | -66.9% | 0.53% | -66.5% |
| Q4 2021 | $5,674,000 | -9.4% | 120,000 | -36.8% | 1.57% | -12.8% |
| Q3 2021 | $6,262,000 | +183.1% | 190,000 | +442.9% | 1.80% | +195.6% |
| Q2 2021 | $2,212,000 | -18.5% | 35,000 | -61.1% | 0.61% | -26.6% |
| Q3 2020 | $2,715,000 | +153.3% | 90,000 | +157.1% | 0.83% | +99.0% |
| Q4 2019 | $1,072,000 | – | 35,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |